SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013695
Filing Date
2020-11-12
Accepted
2020-11-12 16:05:35
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20200930x10q.htm 10-Q 1028910
2 EX-31.1 armp-20200930ex3114239ef.htm EX-31.1 15597
3 EX-31.2 armp-20200930ex3120cbf62.htm EX-31.2 15383
4 EX-32.1 armp-20200930ex32194088c.htm EX-32.1 7934
5 EX-32.2 armp-20200930ex322030d41.htm EX-32.2 8114
6 GRAPHIC armp-20200930x10q001.jpg GRAPHIC 31939
  Complete submission text file 0001558370-20-013695.txt   4339179

Data Files

Seq Description Document Type Size
7 EX-101.INS armp-20200930.xml EX-101.INS 788553
8 EX-101.SCH armp-20200930.xsd EX-101.SCH 40657
9 EX-101.CAL armp-20200930_cal.xml EX-101.CAL 37330
10 EX-101.DEF armp-20200930_def.xml EX-101.DEF 125501
11 EX-101.LAB armp-20200930_lab.xml EX-101.LAB 315386
12 EX-101.PRE armp-20200930_pre.xml EX-101.PRE 273299
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 201306592
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences